AMD (age-related macular degeneration), as most people know, is the leading cause of visual impairment worldwide, most of people over age 60. It affects a tiny part of the retina at the back of your eye, causing a blank patch in the center of your vision.
Jusqu'à présent, il n'existe aucun moyen de guérir la DMLA. Mais la nouvelle technologie d'implantation d'un minuscule télescope à l'intérieur de l'œil, créée par VisionCare Ophthalmic Technology, peut contribuer à améliorer la vision et la qualité de vie des personnes atteintes de DMLA en phase terminale.
Once implanted inside the eye, the telescope projects images in your field of view onto healthy areas of your central retina outside of the degenerated macula. The image is enlarged, reducing the effect the blind spot has on central vision. Normally the healthy areas outside of the macula are used for peripheral or “side vision.” The magnification provided by the telescope implant (2.2X or 2.7X) makes it possible to see or discern the central vision object of interest (From the CentraSight treatment program). However, experts warn it’s not the kind of vision that would allow a patient suffering with AMD to drive again.
To qualify for the surgery, patients need to be at least 75 years old, have end-stage macular degeneration in both eyes, and have at least one eye that has not undergone cataract surgery.
The telescope implant approved by FDA is available nationwide. Contact CentraSight by free call 877-99-SIGHT (1-877-997-4448)
